These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 24641632)

  • 1. Combination of psychological intervention and phosphodiesterase-5 inhibitors for erectile dysfunction: a narrative review and meta-analysis.
    Schmidt HM; Munder T; Gerger H; Frühauf S; Barth J
    J Sex Med; 2014 Jun; 11(6):1376-91. PubMed ID: 24641632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of PDE5 inhibitors alone or in combination with alpha-blockers for the treatment of erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Yan H; Zong H; Cui Y; Li N; Zhang Y
    J Sex Med; 2014 Jun; 11(6):1539-45. PubMed ID: 24621088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis.
    Mykoniatis I; Pyrgidis N; Sokolakis I; Ouranidis A; Sountoulides P; Haidich AB; van Renterghem K; Hatzichristodoulou G; Hatzichristou D
    JAMA Netw Open; 2021 Feb; 4(2):e2036337. PubMed ID: 33599772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M; Corona G; Salvi M; Vignozzi L; McVary KT; Kaplan SA; Roehrborn CG; Serni S; Mirone V; Carini M; Maggi M
    Eur Urol; 2012 May; 61(5):994-1003. PubMed ID: 22405510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.
    Wang X; Wang X; Liu T; He Q; Wang Y; Zhang X
    PLoS One; 2014; 9(3):e91327. PubMed ID: 24618671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOP conservative (medical and mechanical) treatment of erectile dysfunction.
    Porst H; Burnett A; Brock G; Ghanem H; Giuliano F; Glina S; Hellstrom W; Martin-Morales A; Salonia A; Sharlip I;
    J Sex Med; 2013 Jan; 10(1):130-71. PubMed ID: 23343170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the psychosocial outcomes associated with erectile dysfunction: does the impact of erectile dysfunction extend beyond a man's inability to have sex?
    McCabe MP; Althof SE
    J Sex Med; 2014 Feb; 11(2):347-63. PubMed ID: 24251371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of short- and long-term, regular and on-demand regimens of phosphodiesterase type 5 inhibitors in treating erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis.
    Tian D; Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2017; 12():405-412. PubMed ID: 28260869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Antioxidants Supplementation on Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Su L; Yang ZT; Qu H; Luo CL; Yuan GX; Wu J; Jiao YZ
    Sex Med Rev; 2022 Oct; 10(4):754-763. PubMed ID: 35246405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for sexual dysfunction following treatments for cancer.
    Miles CL; Candy B; Jones L; Williams R; Tookman A; King M
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005540. PubMed ID: 17943864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of psychological interventions for the treatment of erectile dysfunction: systematic review and meta-analysis, including comparisons to sildenafil treatment, intracavernosal injection, and vacuum devices.
    Melnik T; Soares BG; Nasello AG
    J Sex Med; 2008 Nov; 5(11):2562-74. PubMed ID: 18564156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Antioxidants Supplementation on Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Su L; Yang ZT; Qu H; Luo CL; Yuan GX; Wu J; Jiao YZ
    Sex Med Rev; 2022 Oct; 10(4):754-763. PubMed ID: 37051969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
    Scaglione F; Donde S; Hassan TA; Jannini EA
    Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.
    Lasaponara F; Sedigh O; Pasquale G; Bosio A; Rolle L; Ceruti C; Timpano M; Negro CL; Paradiso M; Abbona A; Segoloni GP; Fontana D
    J Sex Med; 2013 Nov; 10(11):2798-814. PubMed ID: 23346948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of phosphodieterase-5 inhibitors for treatment of erectile dysfunction secondary to spinal cord injury: a systemic review and meta-analysis.
    Jia DD; Shuang WB; Cheng T; Jia XM; Zhang M
    Spinal Cord; 2016 Jul; 54(7):494-501. PubMed ID: 26882490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis.
    García-Perdomo HA; Echeverría-García F; Tobías A
    Urol Int; 2017; 98(2):198-204. PubMed ID: 27509143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
    Hatzimouratidis K; Salonia A; Adaikan G; Buvat J; Carrier S; El-Meliegy A; McCullough A; Torres LO; Khera M
    J Sex Med; 2016 Apr; 13(4):465-88. PubMed ID: 27045254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.